Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHB2200138	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2022-09-18					view
JXHB2200139	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2022-09-18					view
JXHB2200140	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2022-09-18					view
JXHB2200141	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2022-09-18					view
JXHB2200142	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2022-09-18					view
JXHB2400102	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-06-14					view
JXHB2400103	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-06-14					view
JXHB2400104	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-06-14					view
JXHB2400105	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-06-14					view
JXHB2400106	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-06-14					view
JXHB2400107	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-06-14					view
JXHB2400108	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-06-14					view
JXHB2400159	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-09-30					view
JXHB2400160	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-09-30					view
JXHB2400161	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-09-30					view
JXHB2400162	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-09-30					view
JXHB2400163	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-09-30					view
JXHB2400164	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-09-30					view
JXHB2400165	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2024-09-30					view
JXHL2000335	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2020-12-21	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2020-12-19	view